Reconstruction After Abdominoperineal Resection With Robot-assisted Harvest of VRAM Flap

Sponsor
Oslo University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05689775
Collaborator
(none)
40
1
52
0.8

Study Details

Study Description

Brief Summary

Non-randomized study of robot-assisted perineal reconstruction with rectus abdominis muscle flap in patients operated with abdominoperineal resection for irradiated locally advanced rectal or anal cancer. Operative time, complications, wound healing, pre- and postoperatively abdominal wall strength and patient related outcomes including sexual health will be registered.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Reconstruction with robot-assisted rectus abdominis muscle flap

Detailed Description

Inclusion criteria:

Patients > 18 years of age operated with robotic-assisted abdominoperineal resection for irradiated locally advanced rectal or anal cancer where robotic-assisted perineal and/or vaginal reconstruction has been performed with a rectus abdominis muscle flap.

Methods Up to 40 patients operated with robotic-assisted abdominoperineal resection with Da Vinci Xi surgical system (Intuitive Surgical, Sunnyvale, California, USA) and robotic-assisted reconstruction with a pedicled rectus muscle will be included in this prospective, non-randomized study.

In addition to the standardized post-operative care for patients with locally advanced rectal or anal cancer as specified by national guidelines, patients will be offered study-specific follow-up visits at 1, 6 and 12 months.

Complications are recorded by the accordion severity grading system of surgical complications. Patient related outcomes measures will be registered by using European organization for research and treatment of cancer Quality of life questionnaire Core 30 (EORTC QLQ-C30). Sexual health will be registered by a subset of questions from European organization for research and treatment of cancer Quality of life questionnaire Sexual health (EORTC QLQ-SH22).

Primary endpoint:
  • perineal wound healing at 3 months
Secondary endpoints:
  • early (< 30 days) and late (> 30 days) complications

  • quality of life preoperatively and at 3- and 12 months postoperatively

  • sexual function preoperatively and at 3- and 12 months postoperatively

  • clinical evaluation of abdominal wall strength preoperatively, at 3- and 12 months postoperatively

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
40 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Reconstruction After Abdominoperineal Resection With Robot-assisted Harvest of VRAM Flap
Actual Study Start Date :
Sep 1, 2022
Anticipated Primary Completion Date :
Dec 31, 2024
Anticipated Study Completion Date :
Dec 31, 2026

Arms and Interventions

Arm Intervention/Treatment
Patients

Patients over 18 years of age operated for locally advanced anal or rectal cancer with robot-assisted abdomino-perinal resection and robot-assisted reconstruction of pelvic floor and/or vagina with vertical rectus abdomínis muscle flap.

Procedure: Reconstruction with robot-assisted rectus abdominis muscle flap
Reconstruction of perineum and/or vagina with robot-assisted rectus abdominis muscle flap.

Outcome Measures

Primary Outcome Measures

  1. Perineal wound healing [3 months]

    Perineal wound healing at 3 months. Perineal wound has completely healed at clinical control 3 months postoperatively without need for further follow-up of the perineal wound. Any perineal complications are noted. superficial wound infection deep wound infection minor wound dehiscence major wound dehiscence partial flap loss total flap loss perineal hernia enterocutaneous fistula stricture in neovagina perineal wound dehiscence not related to flap other complications

Secondary Outcome Measures

  1. Early postoperative complications [Within 30 days postoperatively]

    Early postoperative complications at 30 days. A. Abdominal/donor-site complications superficial wound infection deep wound infection minor wound dehiscence major wound dehiscence abdominal hernia other complications B. Perineal complications superficial wound infection deep wound infection minor wound dehiscence major wound dehiscence partial flap loss total flap loss perineal hernia enterocutaneous fistula stricture in neovagina perineal wound dehiscence not related to flap other complications C. Other complications incisional hernia parastomal hernia reoperation other complications Complications are classified as mild, moderate or severe according to Accordion severity grading system (Strasberg SM, Linehan DC, Hawkins WG. The Accordion severity grading system of surgical complications. Ann Surg 2009; 250: 177-86.)

  2. Late postoperative complications [Later than 30 days postoperatively]

    Late postoperative complications Perineal wound healing at 3 months. A. Abdominal/donor-site complications superficial wound infection deep wound infection minor wound dehiscence major wound dehiscence abdominal hernia other complications B. Perineal complications superficial wound infection deep wound infection minor wound dehiscence major wound dehiscence partial flap loss total flap loss perineal hernia enterocutaneous fistula stricture in neovagina perineal wound dehiscence not related to flap other complications C. Other complications incisional hernia parastomal hernia reoperation other complications Complications are classified as mild, moderate or severe according to Accordion severity grading system (Strasberg SM, Linehan DC, Hawkins WG. The Accordion severity grading system of surgical complications. Ann Surg 2009; 250: 177-86.)

  3. Quality of life - general [Preoperatively. 3 months and 12 months postoperatively.]

    Quality of life - EORTC-QLQ-C30

  4. Quality of life - sexual [Preoperatively. 3 months and 12 months postoperatively.]

    Quality of life - EORTC-QLQ-SH22 - excerpt

  5. Abdominal wall strength [Preoperatively. 3 months and 12 months postoperatively.]

    Clinical test of abdominal wall strength as described in (Nelson JA et al. Function and strength after free abdominally based breast reconstruction: A 10-year follow- up. Plastic and reconstructive surgery. 2019;143(1):22e-31e.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • patients with rectal or anal cancer

  • scheduled for robot-assisted abdominoperineal resection

  • reconstruction of pelvic floor and/or vagina with rectus abdominis muscle flap

Exclusion Criteria:
  • patients not eligible for robot-assisted procedure

  • rectus abdominis muscle not available for harvest

  • the expected wound defect is not suitable for reconstruction with rectus abdominis muscle flap

Contacts and Locations

Locations

Site City State Country Postal Code
1 Oslo University Hospital, Radiumhospitalet Oslo Norway 0424

Sponsors and Collaborators

  • Oslo University Hospital

Investigators

  • Principal Investigator: Lars Frich, MD, PhD, Oslo University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Lars Frich, Consultant, Oslo University Hospital
ClinicalTrials.gov Identifier:
NCT05689775
Other Study ID Numbers:
  • 387180
First Posted:
Jan 19, 2023
Last Update Posted:
Jan 19, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Lars Frich, Consultant, Oslo University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 19, 2023